These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27890824)

  • 41. Detection of Drug-Exposed Newborns.
    Wabuyele SL; Colby JM; McMillin GA
    Ther Drug Monit; 2018 Apr; 40(2):166-185. PubMed ID: 29419722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS.
    de Castro A; Díaz A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M; Concheiro M
    Anal Bioanal Chem; 2013 May; 405(12):4295-305. PubMed ID: 23397092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. False-positive and false-negative rates in meconium drug testing.
    Moore C; Lewis D; Leikin J
    Clin Chem; 1995 Nov; 41(11):1614-6. PubMed ID: 7586551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy].
    García-Serra J; Ramis J; Simó S; Joya X; Pichini S; Vall O; García-Algar O
    An Pediatr (Barc); 2012 Nov; 77(5):323-8. PubMed ID: 22513392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population.
    Shor S; Nulman I; Kulaga V; Koren G
    Alcohol; 2010; 44(7-8):623-7. PubMed ID: 20031369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
    Pichini S; Puig C; Zuccaro P; Marchei E; Pellegrini M; Murillo J; Vall O; Pacifici R; García-Algar O
    Forensic Sci Int; 2005 Oct; 153(1):59-65. PubMed ID: 15923097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug Positivity Findings from a Universal Umbilical Cord Tissue Drug Analysis Program in Appalachia.
    Yossuck P; Tacker DH
    J Appl Lab Med; 2021 Jan; 6(1):285-297. PubMed ID: 33324976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LC-MS: a powerful tool in workplace drug testing.
    Gallardo E; Barroso M; Queiroz JA
    Drug Test Anal; 2009 Mar; 1(3):109-15. PubMed ID: 20355182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of substance abuse monitoring in a social services context: a primer for child protection workers.
    Moller M; Gareri J; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e177-93. PubMed ID: 20436210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption.
    Joya X; Marchei E; Salat-Batlle J; García-Algar O; Calvaresi V; Pacifici R; Pichini S
    Drug Test Anal; 2016 Aug; 8(8):864-8. PubMed ID: 26627903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine.
    Casanova OQ; Lombardero N; Behnke M; Eyler FD; Conlon M; Bertholf RL
    Arch Pathol Lab Med; 1994 Oct; 118(10):988-93. PubMed ID: 7944901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical detection of meconium in the fetal membrane, placenta and umbilical cord.
    Furuta N; Yaguchi C; Itoh H; Morishima Y; Tamura N; Kato M; Uchida T; Suzuki K; Sugihara K; Kawabata Y; Suzuki N; Sasaki T; Horiuchi K; Kanayama N
    Placenta; 2012 Jan; 33(1):24-30. PubMed ID: 22041294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.
    Ostrea EM; Brady M; Gause S; Raymundo AL; Stevens M
    Pediatrics; 1992 Jan; 89(1):107-13. PubMed ID: 1727992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug testing in the neonate.
    Cotten SW
    Clin Lab Med; 2012 Sep; 32(3):449-66. PubMed ID: 22939302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of Neonatal Co-Exposure to Gabapentin and Commonly Abused Drugs Observed in Umbilical Cord Tissue.
    Okoye NC; McMillin GA
    J Anal Toxicol; 2021 May; 45(5):506-512. PubMed ID: 32860706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meconium-induced umbilical cord vascular necrosis and ulceration: a potential link between the placenta and poor pregnancy outcome.
    Altshuler G; Arizawa M; Molnar-Nadasdy G
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):760-6. PubMed ID: 1565362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis.
    Ostrea EM
    Curr Probl Pediatr; 1999 Feb; 29(2):37-56. PubMed ID: 10021686
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of a liquid chromatography-tandem mass spectrometry method to address the increased utilization of umbilical cord in the assessment of in utero drug exposure.
    Haglock-Adler CJ; McMillin GA; Strathmann FG
    Clin Biochem; 2016 Sep; 49(13-14):1092-5. PubMed ID: 27131494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.